Atlas Trials

A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer

Clinical trial NCT01676259 · UNKNOWN

Trial details

NCT number
NCT01676259
Sponsor
Silenseed Ltd
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Start date
2018-03-07
Primary completion
2022-10-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.